Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Clinical trial NCT03647358 · RECRUITING
Trial details
- NCT number
- NCT03647358
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2027-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.